Coelho, H., Badior, M., & Melo, T. Sequential Kinase Inhibition (Idelalisib/Ibrutinib) Induces Clinical Remission in B-Cell Prolymphocytic Leukemia Harboring a 17p Deletion. Wiley.
Chicago Style (17th ed.) CitationCoelho, H., M. Badior, and T. Melo. Sequential Kinase Inhibition (Idelalisib/Ibrutinib) Induces Clinical Remission in B-Cell Prolymphocytic Leukemia Harboring a 17p Deletion. Wiley.
MLA (9th ed.) CitationCoelho, H., et al. Sequential Kinase Inhibition (Idelalisib/Ibrutinib) Induces Clinical Remission in B-Cell Prolymphocytic Leukemia Harboring a 17p Deletion. Wiley.
Warning: These citations may not always be 100% accurate.